Crispr Technology Market by Application and Geography - Forecast and Analysis 2022-2026

The CRISPR technology market share is projected to rise to USD 2.88 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 19.34%.

This CRISPR technology market research report extensively covers market segmentations by the following:

• Application - Biological application, agricultural application, industrial application, and others 
• Geography - North America, Europe, Asia, and Rest of World (ROW)

The CRISPR-Cas9 technology market report covers several market vendors, including Addgene Inc., Agilent Technologies Inc., Applied StemCell Inc., Caribou Biosciences Inc., Cellecta Inc., CRISPR Therapeutics AG, Danaher Corp., Editas Medicine Inc., GeneCopoeia Inc., GenScript Biotech Corp., Intellia Therapeutics Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, New England Biolabs Inc., Novartis AG, OriGene Technologies Inc., PerkinElmer Inc., Synthego Corp., and Thermo Fisher Scientific Inc. among others. Furthermore, this report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches.

What will the CRISPR Technology Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the CRISPR Technology Market Size for the Forecast Period and Other Important Statistics

 

CRISPR Technology Market: Key Drivers, Trends, and Challenges

The increasing demand for treatment of genetic diseases is notably driving the CRISPR technology market growth, although factors such as ethical issues associated with CRISPR technology may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the CRISPR technology industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key CRISPR Technology Market Driver

One of the key factors driving the global CRISPR technology industry growth is the increasing demand for the treatment of genetic diseases. The evolving landscape of CRISPR technology could end the after-effects of incurable diseases. CRISPR technology offers an opportunity to treat fatal and incurable genetic diseases. The demand for CRISPR technology is increasing as it is easy, fast, and gives inexpensive access to vectors. CRISPR technology has made gene editing possible and the treatment of sickle cell disease and B-thalassemia, Huntingtons', and Parkinsons' diseases. The effective cure of hereditary blindness and cancer using gene therapy is also in the pipeline. The R&D in CRISPR will allow gene editing at a much more granular level and enable the easy removal of any misbehaving gene, which is expected to decrease the effects of deadly genetic diseases such as cystic fibrosis in the forecast period.

Key CRISPR Technology Market Trend

Advent of CRISPR/ Cas9 is one of the key CRISPR-Cas9 technology market trends that is expected to impact the industry positively in the forecast period. Technological advances such as AI, ML, blockchain, advanced analytics, Big Data, IoT, AR, and virtual reality (VR) are expected to pave the way for the adoption of progressive business solutions. Significant investments in R&D have resulted in several technological advances such as CRISPR/Cas9, which is a fast, accurate, efficient, and cost-effective genome editing tool. CRISPR/Cas9 allows researchers to edit parts of the genome by editing the DNA sequence safely and altering the entire gene function. Several other gene-editing technologies, such as transcription activator-like effector nucleases (TALEN) and zinc-finger nucleases (ZFN), have also been launched in the market. 

Key CRISPR Technology Market Challenge

One of the key challenges to the global CRISPR technology industry growth is the ethical issues associated with CRISPR technology. Gene editing is considered unethical as it is associated with the injection of genes into a body and altering the entire gene structure of an organism. For instance, germline modification using CRISPR technology, which specifically targets the egg and sperm cells, enables the inserted gene to be passed on to future generations. The use of such sophisticated gene therapies may trigger an ethical debate across the world, which is a key challenge for the growth of the global CRISPR market. In the US, federal funds cannot be used for research related to CRISPR technology as it is considered unethical. Such factors may limit the growth of the market in the forecast years.

This clustered regularly interspaced short palindromic repeats technology market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Who are the Major CRISPR Technology Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

• Addgene Inc.
• Agilent Technologies Inc.
• Applied StemCell Inc.
• Caribou Biosciences Inc.
• Cellecta Inc.
• CRISPR Therapeutics AG
• Danaher Corp.
• Editas Medicine Inc.
• GeneCopoeia Inc.
• GenScript Biotech Corp.
• Intellia Therapeutics Inc.
• Lonza Group Ltd.
• Merck KGaA
• Mirus Bio LLC
• New England Biolabs Inc.
• Novartis AG
• OriGene Technologies Inc.
• PerkinElmer Inc.
• Synthego Corp.
• Thermo Fisher Scientific Inc.

This statistical study of the market encompasses successful business strategies deployed by the key vendors. The CRISPR-Cas9 technology market is fragmented and the vendors are deploying growth strategies such as investment in R&D to compete in the market.

Product Insights and News

• Agilent Technologies Inc. - The life sciences and applied markets segment provide application-focused solutions that include instruments and software to identify, quantify, and analyze the physical and biological properties of substances and products.
• Danaher Corp. - The company offers Alt-R CRISPR-Cas9 System, which is an optimized genome editing solution that outperforms other CRISPR approaches for producing on-target, double-stranded DNA breaks.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The CRISPR technology market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Which are the Key Regions for CRISPR Technology Market?

For more insights on the market share of various regions Request for a FREE sample now!

44% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for CRISPR technology in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.

The increasing spending on research, the presence of biotechnology companies and vendors that offer gene-editing services, and the high focus on biomedical research by universities and research institutions will facilitate the CRISPR technology market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The COVID-19 pandemic had a positive impact on the regional CRISPR technology market in 2020. CRISPR technology is being used in studying the coronavirus and diagnosing the disease. For instance, the CRISPR-Cas system was being investigated for rapid and specific diagnosis of COVID-19 in 2020. The CRISPR-Cas-based technology helps in diagnosing the SARS-CoV-2 infections within an hour. Further, in March 2021, the US Food and Drug Administration (FDA) approved the first-in-human clinical trial of a CRISPR gene correction therapy with patients having sickle cell disease to scientists from the University of California San Francisco, University of California, Berkeley, and University of California, Los Angeles. Therefore, the market will witness growth during the forecast period.

What are the Revenue-generating Application Segments in the CRISPR Technology Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The CRISPR technology market share growth by the biological application segment will be significant during the forecast period. The growth of the segment is attributed to the increasing number of biomedical research studies being conducted in universities and research institutions. This is due to increasing awareness about the need for multidisciplinary and interdisciplinary genetics research studies to treat complex diseases and disorders has given a boost to biomedical research.

This report provides an accurate prediction of the contribution of all the segments to the growth of the CRISPR-Cas9 technology market size and actionable market insights on the post-COVID-19 impact on each segment.

Parent Market Analysis

Technavio categorizes the global clustered regularly interspaced short palindromic repeats (CRISPR) technology market as a part of the healthcare technology market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the CRISPR technology market during the forecast period.

CRISPR Technology Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the CRISPR technology market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

You may be interested in:

Bioprocess Technology market - The market share is expected to increase to USD 55.84 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 12.27%.

Agricultural Biologicals market - The market share has the potential to grow by USD 10.23 billion during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 14.61%.

CRISPR Technology Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 19.34%
Market growth 2022-2026	USD 2.88 billion
Market structure	Fragmented
YoY growth (%)	18.25
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 44%
Key consumer countries	US, Canada, UK, Germany, and Japan
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Addgene Inc., Agilent Technologies Inc., Applied StemCell Inc., Caribou Biosciences Inc., Cellecta Inc., CRISPR Therapeutics AG, Danaher Corp., Editas Medicine Inc., GeneCopoeia Inc., GenScript Biotech Corp., Intellia Therapeutics Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, New England Biolabs Inc., Novartis AG, OriGene Technologies Inc., PerkinElmer Inc., Synthego Corp., and Thermo Fisher Scientific Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this CRISPR Technology Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive CRISPR-Cas9 technology market growth during the next five years
• Precise estimation of the CRISPR technology market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the CRISPR technology industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of CRISPR technology market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch